INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 3.640
-0.460 (-11.22%)
At close: Apr 1, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 391.21 million as of April 2, 2026. Its market cap has decreased by -23.72% in one year.
Market Cap
391.21M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.64
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 391.21M, a decrease of -13.52%. That is a compound annual growth rate of -3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 391.21M | 2.44% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.91B |
| Circio Holding ASA | 2.32B |
| Nordhealth AS | 2.21B |
| Thor Medical ASA | 1.77B |
| Lytix Biopharma AS | 799.76M |
| Gentian Diagnostics ASA | 601.47M |
| Zelluna ASA | 493.35M |
| Navamedic ASA | 474.83M |